Strata Skin Sciences (SSKN) Financials

$0.01

$0.00 (0.00%)

As on 17-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$31 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	30.70	33.56	33.36	36.16	29.98	23.09
Cost of Revenue	12.82	14.48	14.90	14.39	10.13	8.96
Gross Profit	17.88	19.08	18.46	21.77	19.85	14.13
Operating Expenses	23.72	28.34	27.07	26.42	24.25	18.21
Operating Profit (EBIT)	-5.84	-9.26	-8.60	-4.65	-4.40	-4.08
Other Income	--	--	--	--	--	--
Profit before Tax	-6.25	-10.26	-10.92	-5.49	-2.67	-4.14
Provision for Tax	0.01	-0.17	-0.09	0.06	0.03	0.28
Profit after Tax (Net Income)	-6.26	-10.09	-10.83	-5.55	-2.71	-4.41
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-2.71	-4.41

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	2.91	4.97	12.69	21.83	25.41	25.89
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.87	16.56	17.15	17.02	8.38	2.05
Current Liabilities	26.74	14.63	12.17	13.43	12.80	18.84
Total Liabilities	30.52	36.16	42.02	52.27	46.59	46.78

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	14.92	19.56	26.47	34.77	26.62	21.95
Current Assets	15.60	16.60	15.54	17.50	19.97	24.83
Total Assets	30.52	36.16	42.02	52.27	46.59	46.78
Total Debt*	16.27	16.44	15.63	8.44	8.03	10.88
Net Current Assets	-11.14	1.97	3.37	4.08	7.17	5.99

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-2.79	0.19	-0.52	-1.11	1.51	2.10
Cash Flow from Investing Activities	-1.47	-1.64	-5.02	-4.18	-7.13	-2.16
Cash from Financing Activities	3.58	1.93	6.86	-0.50	0.09	2.55
Net Cash Inflow / Outflow	--	--	--	--	--	2.48

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.06	-0.26	-0.31	-0.16	-0.08	-0.13
Cash EPS ($)	-0.30	-0.13	-0.14	0.00	0.04	-0.01
Adjusted Book Value ($)	0.49	0.13	0.36	0.63	0.74	0.77
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.47	0.00	-0.01	-0.03	0.04	0.06
Free Cash Flow per Share ($)	-0.72	-0.04	-0.16	-0.13	-0.06	0.00

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-30.85	-40.56	-36.97	-17.42	-7.71	-11.91
ROE (%)	-158.91	-114.22	-62.75	-23.49	-10.55	-16.18
ROA (%)	-18.78	-25.80	-22.97	-11.23	-5.80	-9.38
EBIT Margin (%)	-13.98	-24.28	-27.83	-12.61	-7.87	-17.00
Net Margin (%)	-20.40	-30.05	-32.47	-15.35	-9.03	-19.11
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.09	0.01	-0.08	0.21	0.30	-0.27
EBIT Growth (%)	47.36	12.21	-103.55	-93.38	39.94	-30.43
Net Profit Growth (%)	37.92	6.87	-95.17	-105.06	38.67	-16.41
EPS Growth (%)	-3.01	0.14	-0.93	-1.03	0.40	-0.13
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-1.18	-10.98	-1.78	-4.94	-18.61	-11.49
Price / Book Value	2.55	22.28	1.52	1.26	1.98	1.96
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	89.13	-42.21	-8.32	26.99	26.50	-3,397.18
Close Price ($)	1.26	2.91	5.50	7.90	14.65	15.00
High Price ($)	3.86	6.41	13.90	18.20	28.40	25.30
Low Price ($)	1.18	2.51	2.60	7.40	13.00	7.52
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	5.59	3.31	1.23	0.39	0.32	0.42
Short term debt to equity ratio	5.36	0.07	0.03	0.02	0.01	0.35
Current Ratio	0.58	1.13	1.28	1.30	1.56	1.32
Quick Ratio	0.48	0.98	1.06	0.89	1.29	1.14
Interest Coverage	-2.19	-3.87	-5.66	-4.92	-7.51	-18.61

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	13.43	15.65	13.31	12.36	11.45	12.75
Asset Turnover	0.92	0.86	0.71	0.73	0.64	0.49
Receivable days	55.77	52.74	48.79	39.92	38.85	57.97
Inventory Days	72.11	62.04	100.77	114.65	125.03	131.95
Payable days	73.98	72.84	82.97	79.26	100.73	94.70
Cash Conversion Cycle	53.90	41.94	66.59	75.31	63.14	95.23